Digital intervention to improve mindsets in young cancer survivors
EMBody ('Exploring Mindsets About the Body'): Harnessing Adaptive Body Mindsets to Improve Outcomes in Childhood & AYA Cancer Survivors
This study tests whether a digital program that includes films and activities can help young cancer survivors aged 16-25 improve their mental health and wellbeing.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 105 (estimated) |
| Ages | 16 Years to 25 Years |
| Sex | All |
| Sponsor | King's College London Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT06702371 on ClinicalTrials.gov |
What this trial studies
This study evaluates the EMBody digital body mindset intervention designed for young cancer survivors aged 16-25. The intervention includes documentary-style films and reflection activities aimed at fostering adaptive mindsets and enhancing health and wellbeing. Participants will be divided into two groups: one receiving the EMBody intervention and another serving as a waitlist control. The study seeks to determine the effectiveness of this intervention in improving mental health outcomes compared to the control group.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 16-25 who have completed cancer treatment within the last seven years.
Not a fit: Patients currently undergoing cancer treatment or those with significant cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the mental health and wellbeing of young cancer survivors.
How similar studies have performed: Previous studies have shown promise in using digital interventions to improve mental health outcomes, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ages 16-25 years * Previously received a cancer diagnosis including but not limited to leukemia, Hodgkins/non-Hodgkins lymphoma, osteosarcoma, Ewing sarcoma, or CNS tumour * Completed active, primary cancer treatment * Are up to seven years off treatment Exclusion Criteria: * Significant cognitive impairment that would interfere with engagement with digital materials * Not able read or write in English * Active suicidal intent * Currently receiving active treatment for primary or secondary cancer * Completed cancer treatment more than seven years ago
Where this trial is running
London
- The Royal Marsden — London, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Lauren C Heathcote, PhD — King's College London
- Study coordinator: Lauren C Heathcote, PhD
- Email: lauren.heathcote@kcl.ac.uk
- Phone: +44 2071882597
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.